Industry Discovery & Development Partnership (IDDP) Program
Breakthrough T1D's IDDP Program funds for-profit companies to develop innovative therapies or devices for type 1 diabetes with a focus on scientific advancement and commercialization.
Funder: Breakthrough T1D
Due Dates: Rolling (LOIs accepted year-round; by invitation or in response to RFAs)
Funding Amounts: No fixed maximum; award size and duration are negotiated; company match required (≥ Breakthrough T1D funds requested).
Summary: Supports for-profit organizations developing therapies or devices for type 1 diabetes that align with Breakthrough T1D’s priority research areas and commercial potential.
Key Information: LOI and pre-application discussion with Breakthrough T1D staff are required before submission.
Description
The Industry Discovery & Development Partnership (IDDP) Program from Breakthrough T1D funds for-profit entities—such as biotechnology, pharmaceutical, and device companies—to advance research projects with clear potential for type 1 diabetes (T1D) treatment, cure, or prevention. The program is designed to leverage the commercial sector’s capacity for innovation and product development, while benefiting from Breakthrough T1D’s leadership in T1D research and advocacy. Projects must closely align with Breakthrough T1D’s strategic research priorities and demonstrate a clear path to commercialization.
IDDP awards are milestone-driven and require active collaboration between the company and Breakthrough T1D staff, including participation in a joint research advisory committee and regular progress reporting. Projects may involve partnerships with academic investigators or contract research organizations.
